DNA methylation biomarkers of stool and blood for early detection of colon cancer

Genetic Testing and Molecular Biomarkers

Volumn 17, Issue 5, 2013, Pages 401-406

  Hong, Liu ^a   Ahuja, Nita ^b  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; NEUROGENIN 1; TRANSCRIPTION FACTOR RUNX3;

ALX4 GENE; ARTICLE; BLOOD ANALYSIS; CANCER DIAGNOSIS; CANCER SCREENING; CARCINOGENESIS; CDH4 GENE; CLINICAL RESEARCH; COLON CANCER; COLONOSCOPY; DAPK1 GENE; DNA METHYLATION; EARLY CANCER; FECES ANALYSIS; HOSPITAL; HUMAN; NGFR GENE; SENSITIVITY ANALYSIS; SERUM; TMEFF2 GENE; TUMOR GENE;

BIOLOGICAL MARKERS; COLONIC NEOPLASMS; DNA METHYLATION; EARLY DETECTION OF CANCER; FECES; GENETIC MARKERS; HUMANS; POLYMERASE CHAIN REACTION;

EID: 84876937056     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2012.0478     Document Type: Article

References (31)

1. Ausch C, Kim YH, Tsuchiya KD, et al. (2009) Comparative analysis of PCR-based biomarker assay methods for colo-rectal polyp detection from fecal DNA. Clin Chem 55:1559-1563.
2. Bosch LJ, Oort FA, Neerincx M, et al. (2012) DNA methylation of phosphatase and actin regulator 3 detects colorectal cancer in stool and complements FIT. Cancer Prev Res 5:464-472.
3. Chen WD, Han ZJ, Skoletsky J, et al. (2005) Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene. J Natl Cancer Inst 97:1124-1132.
4. Davies RJ, Miller R, Coleman N (2005) Colorectal cancer screening: prospects for molecular stool analysis. Nat Rev Cancer 5:199-209.
5. Ebert MP, Model F, Mooney S, et al. (2006) Aristaless-like homeobox-4 gene methylation is a potential marker for colorectal adenocarcinomas. Gastroenterology 131:1418-1430.
6. Goebel G, Müller HM, Fiegl H, Widschwendter M (2005) Gene methylation data-a new challenge for bioinformaticians? Methods Inf Med 44:516-519.
7. Hellebrekers DM, Lentjes MH, van den Bosch SM, et al. (2009) GATA4 and GATA5 are potential tumor suppressors and biomarkers in colorectal cancer. Clin Cancer Res 15:3990-3997.
8. Hibi K, Nakao A (2006) Highly-methylated colorectal cancers show poorly-differentiated phenotype. Anticancer Res 26: 4263-4266.
9. Herbst A, Rahmig K, Stieber P, et al. (2011) Methylation of NEUROG1 in serum is a sensitive marker for the detection of early colorectal cancer. Am J Gastroenterol 106:1110-1118.
10. Jensen LH, Lindebjerg J, Byriel L, Kolvraa S, Crüger DG (2008) Strategy in clinical practice for classification of unselected colorectal tumours based on mismatch repair deficiency. Colorectal Dis 10:490-497.
11. Kim MS, Lee J, Sidransky D (2010) DNA methylation markers in colorectal cancer. Cancer Metastasis Rev 29:181-206.
12. Kim MS, Louwagie J, Carvalho B, et al. (2009) Promoter DNA methylation of oncostatin m receptor-beta as a novel diagnostic and therapeutic marker in colon cancer. PLoS One 4:e6555.
13. Lofton-Day C, Model F, Devos T, et al. (2008) DNA methylation biomarkers for blood-based colorectal cancer screening. Clin Chem 54:414-423.
14. Lecomte T, Berger A, Zinzindohoué F, et al. (2002) Detection of free-circulating tumor-associated DNA in plasma of colorectal cancer patients and its association with prognosis. Int J Cancer 100:542-548.
15. Leung WK, To KF, Man EP, et al. (2005) Quantitative detection of promoter hypermethylation in multiple genes in the serum of patients with colorectal cancer. Am J Gastroenterol 100:2274-2279.
16. Lenhard K, Bommer GT, Asutay S, et al. (2005) Analysis of promoter methylation in stool: a novel method for the detection of colorectal cancer. Clin Gastroenterol Hepatol 3:142-149.
17. Müller HM, Oberwalder M, Fiegl H, et al. (2004) Methylation changes in faecal DNA: a marker for colorectal cancer screening? Lancet 363:1283-1285.
18. Melotte V, Lentjes MH, van den Bosch SM, et al. (2009) N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer. J Natl Cancer Inst 101:916-927.
19. Miotto E, Sabbioni S, Veronese A, et al. (2004) Frequent aberrant methylation of the CDH4 gene promoter in human colorectal and gastric cancer. Cancer Res 64:8156-8159.
20. Nakayama H, Hibi K, Taguchi M, et al. (2002) Molecular detection of p16 promoter methylation in the serum of colorectal cancer patients. Cancer Lett 188:115-119.
21. Nishio M, Sakakura C, Nagata T, et al. (2010) RUNX3 promoter methylation in colorectal cancer: its relationship with microsatellite instability and its suitability as a novel serum tumor marker. Anticancer Res 30:2673-2682.
22. Payne SR (2010) From discovery to the clinic: the novel DNA methylation biomarker (m)SEPT9 for the detection of colo-rectal cancer in blood. Epigenomics 2:575-585.
23. Petko Z, Ghiassi M, Shuber A, et al. (2005) Aberrantly methylated CDKN2A, MGMT, and MLH1 in colon polyps and in fecal DNA from patients with colorectal polyps. Clin Cancer Res 11:1203-1209.
24. Suzuki H, Gabrielson E, Chen W, et al. (2002) A genomic screen for genes upregulated by demethylation and histone deace-tylase inhibition in human colorectal cancer. Nat Genet 31:141-149.
25. Schetter AJ, Harris CC (2011) Alterations of microRNAs contribute to colon carcinogenesis. Semin Oncol 38:734-742.
26. Sabbioni S, Miotto E, Veronese A, et al. (2003) Multigene methylation analysis of gastrointestinal tumors: TPEF emerges as a frequent tumor-specific aberrantly methylated marker that can be detected in peripheral blood. Mol Diagn 7:201-207.
27. Warren JD, Xiong W, Bunker AM, et al. (2011) Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer. BMC Med 9:133.
28. Wallner M, Herbst A, Behrens A, et al. (2006) Methylation of serum DNA is an independent prognostic marker in colorectal cancer. Clin Cancer Res 12:7347-7352.
29. Zitt M, Zitt M, Müller HM (2007) DNA methylation in colorectal cancer-impact on screening and therapy monitoring modalities? Dis Markers 23:51-71.
30. Zou H, Harrington J, Rego RL, Ahlquist DA (2007) A novel method to capture methylated human DNA from stool: implications for colorectal cancer screening. Clin Chem 53:1646-1651.
31. Zou HZ, Yu BM, Wang ZW, et al. (2002) Detection of aberrant p16 methylation in the serum of colorectal cancer patients. Clin Cancer Res 8:188-191.